In breast cancer cells, NAT10 knockdown reversed docetaxel‐induced EMT and restored sensitivity to docetaxel, as evidenced by upregulated CDH1 (E‐cadherin) expression and downregulated VIM (vimentin) expression.135. This evidence concerns the gene CDH1 and breast cancer.